Quantcast

Latest Clinical research Stories

2014-11-03 08:30:12

-- Trial Met Primary Efficacy Endpoint with Statistical Significance After 12 Weeks of Treatment -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Nov. 3, 2014 /PRNewswire/ -- Eisai Inc.

2014-10-31 23:02:25

Each week FDAnews reporters spend hours talking to the quality managers at recently inspected facilities, surveying them about what happened during the inspection and what caught them by surprise.

2014-10-31 08:26:32

Conference Call Scheduled for Monday, November 3, 2014 at 10:00 a.m. Eastern time JERUSALEM, October 31, 2014 /PRNewswire/ -- Oramed Pharmaceuticals Inc.

2014-10-31 08:26:08

SAN DIEGO, Oct. 31, 2014 /PRNewswire/ -- Mast Therapeutics, Inc.

2014-10-31 08:25:25

FDA states that approval will not be final until Astagraf XL® exclusivity expires; Veloxis is appealing this decision HORSHOLM, Denmark, Oct.

2014-10-31 08:25:16

NEW YORK, Oct. 31, 2014 /PRNewswire/ -- Analyst Brief by Small Cap Traders. Tenax Therapeutics, Inc.

2014-10-30 23:10:48

DMG Productions explores the latest breakthroughs in health and medicine. Zug, Switzerland (PRWEB) October 30, 2014 PSI CRO (PSI) announced that they

2014-10-30 23:08:29

DrugDev is sponsoring and providing speakers for the 13th Annual Partnerships in Clinical Trials Congress in Barcelona, 4-6 November.

2014-10-30 16:29:19

LEXINGTON, Mass., Oct.


Word of the Day
swell-mobsman
  • A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.
Use of the word 'swell-mobsman' dates at least to the early 1800s.